SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial

NCT06674109 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Gout and Hyperuricemia

Interventions

DRUG: Empagliflozin 10 mg
DRUG: Placebo

Sponsor

Massachusetts General Hospital